GlassScriptPhysician profile
Bruce A Mackey
NPI 1891799821
$13,691.83
in general payments reported to CMS, 2019-2025
42 companies · $1,224 in 2025
The $1,224 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,814 · 2020: $1,027 · 2021: $1,612 · 2022: $2,202 · 2023: $1,028 · 2024: $786 · 2025: $1,224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,037.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,036.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Flowonix Medical Incorporated | $4,169.50 | 2019 | |
| Medtronic, INC. | $1,799.15 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Collegium Pharmaceutical, INC. | $1,013.81 | 2019-2025 | Belbuca, Xtampza |
| Boston Scientific Corporation | $795.75 | 2021-2025 | Wavewriter Alpha Prime 16, General - Therapies, Intracept |
| Abbvie INC. | $555.76 | 2022-2025 | |
| Nevro Corp. | $550.94 | 2019-2023 | Senza |
| Abbott Laboratories | $513.33 | 2019-2023 | Proclaim |
| Pfizer INC. | $443.98 | 2019-2025 | |
| Biodelivery Sciences International, INC. | $367.79 | 2019-2021 | |
| Tersera Therapeutics LLC | $351.19 | 2019-2023 | Prialt |
| Teva Pharmaceuticals USA, INC. | $308.14 | 2019-2021 | |
| Inspire Medical Systems, INC. | $298.74 | 2023-2025 | Inspire |
| Amgen INC. | $260.62 | 2019-2022 | |
| Almatica Pharma LLC | $208.22 | 2021-2023 | Gralise |
| Biohaven Pharmaceutical Holding Company LTD. | $202.77 | 2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Mackey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.